News Center
Contact us
中文
About Us
Who we are
Our history
Brand culture
Our Businesses
Pharma
Medical
Diagnostics
Vaccines
Sustainability
EHS Responsibility
Education Projects
Charitable Donations
Community Services
Join us
People Strategy
Our People
Job Opportunities
News Center
Luye Pharma Announces 2025 Half-Year Results
2025-08-29
MORE>
Boan Biotech Announces 2025 Half-Year Results
2025-08-28
MORE>
Boyouping®, China’s First Locally Developed Dulaglutide Injection, Approved for Marketing
2025-08-08
MORE>
Luye Pharma Launches Its Transdermal Patch Rotigotine Luye in the UK for the Treatment of ...
2025-04-11
MORE>
Luye Pharma’s Rivastigmine Twice Weekly Transdermal Patch Approved for Marketing in Japan...
2025-03-31
MORE>
Boan Biotech Announces 2024 Financial Results
2025-03-28
MORE>
Total:
143
/ Page:
24
First
Prev
1
2
3
4
5
Next
Last
鲁ICP备05023892号-5
LUYE All Rights Reserved
Privacy policy
Terms of use
中文
TOP
TOP